The incidence and risk of cardiac events in patients with previously treated multiple myeloma vs. matched patients without multiple myeloma: an observational, retrospective, cohort study

This study provides a unique look at real world cardiac event rates for a large group of MM patients treated with selected anti-myeloma treatments. Cardiac event risk for any cardiac event including hypertensive/arterial events, cardiac dysrhythmias, CHF, IHD, cardiomyopathy, and conduction disorders was greater in MM patients with ≥3 prior drugs (n=1,723) compared to patients without MM (n=8,615).
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Tags: Original Study Source Type: research